Evolutionary Genomics
Lafayette, Colorado, United States
About Evolutionary Genomics
Evolutionary Genomics (EG) is a unique biotechnology company that is changing how relevant gene/target discovery and validation is performed during the post-genomics era. The company's proprietary Adapted Traits platform sifts through vast amounts of genomic data to identify only those genes that have a high likelihood of commercial value for downstream validation. EG applies this platform to identify high-value targets for drug-discovery or genes for use in natural crop yield or pest/disease-resistance enhancement.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $2.5M
- Funding stage: IPO
- Last round: Post-IPO Equity (May 2022)
- Ticker: otcqb:FNAM
- Website: evolgen.com
- Phone: 303-862-3222
Industries & Categories
Biotechnology, Genetics, Medical
Canonical: https://fsome.com/organization/evolutionary-genomics-2246609 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.